$INVA
Innoviva, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Burlingame, CA
INVA chart
What traders are saying about $INVA
Latest postsInnoviva, Inc. news
- Is Innoviva (INVA) Stock Undervalued Right Now?
Yahoo Finance ·
- Innoviva, Inc. (INVA) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- INVA or MRK: Which Is the Better Value Stock Right Now?
Yahoo Finance ·
- Innoviva stock hits 52-week low at 18.98 USD
Investing.com ·
- Innoviva Inc (HVE.SG) Seasonal returns chart
Yahoo Finance Singapore ·
- Innoviva (INVA) Stock Could Be Undervalued On Third Quarter Results
Simply Wall St ·
- Oppenheimer maintains Innoviva at Outperform, lowers price target to $34 from $35
TradingView ·
- Does a USD 139.5 Million Armata Markdown Obscure Innoviva (NASDAQ:INVA) 21.9% Operating Income Gain?
kalkine.ca ·
- Key facts: Innoviva Reports Q3 Results; NUZOLVENCE Launches in U.S.; Three Products Named Prix Galien Finalists
TradingView ·
- Innoviva, Inc. Stock 12‑Month Price Target Cut to $34.8, Implies 64% Upside
TradingView ·
- Innoviva Posts $73.9 Million Net Loss in Q3 2026 Amid Equity Investment Value Declines
Kalkine Media ·
- Innoviva (INVA) Could Be 39% Undervalued Following Third Quarter Loss
Simply Wall St ·
Innoviva, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $411.3M | $358.7M | $310.5M | $331.3M |
| Diluted EPS | $3.30 | $0.36 | $2.20 | $2.37 |
| Total assets (year end) | $1.64B | $1.30B | $1.24B | $1.23B |
| Cash and equivalents (year end) | $550.9M | $305.0M | $193.5M | $291.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Innoviva, Inc.
- Ticker
- INVA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Burlingame, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1080014
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
Frequently asked questions
What exchange is Innoviva, Inc. listed on?
Innoviva, Inc. trades on the Nasdaq under the ticker symbol INVA.
What industry is Innoviva, Inc. in?
Innoviva, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Innoviva, Inc. headquartered?
Innoviva, Inc.'s business address on file with the SEC is in Burlingame, CA.
When does Innoviva, Inc.'s fiscal year end?
Innoviva, Inc.'s fiscal year ends on December 31.
How much revenue did Innoviva, Inc. report?
Innoviva, Inc. reported $411.3M in revenue for calendar year 2025, according to its SEC filings.